NCT04871139View on ClinicalTrials.gov

An Imaging Technology, Contrast-Enhanced Mammography, in Predicting Breast Cancer

NARecruitingINTERVENTIONAL

Enrollment

100

Participants

Timeline

Start Date

April 8, 2021

Primary Completion Date

March 1, 2026

Study Completion Date

March 1, 2026

Conditions

Breast Carcinoma

Interventions

PROCEDURE

Biopsy

Undergo biopsy

PROCEDURE

Contrast-Enhanced Mammography

Undergo CEM

OTHER

Questionnaire Administration

Ancillary studies

OTHER

Radioactive Iodine

Given IV

Trial Locations (1)

77030

RECRUITING

M D Anderson Cancer Center, Houston

All Listed Sponsors

collaborator

National Cancer Institute (NCI)

NIH

lead

M.D. Anderson Cancer Center

OTHER